T119	ZeroArticleNP 0 10	Drug Label
T120	ZeroArticleNP 15 33	drug brand ELIQUIS
T121	IndefiniteNP 213 230	an increased risk
T122	IndefiniteNP 253 270	An increased rate
T123	IndefiniteNP 457 471	a reason other
T124	IndefiniteNP 514 535	another anticoagulant
T125	IndefiniteNP 852 869	an increased risk
T126	IndefiniteNP 892 909	An increased rate
T127	IndefiniteNP 1096 1110	a reason other
T128	IndefiniteNP 1153 1174	another anticoagulant
T129	DefiniteNP 1284 1308	the following conditions
T130	DefiniteNP 1807 1818	the absence
T131	DefiniteNP 1869 1877	the risk
T132	DefiniteNP 1948 1962	the transition
T133	IndefiniteNP 1900 1917	An increased rate
T134	IndefiniteNP 2093 2107	a reason other
T135	IndefiniteNP 2159 2180	another anticoagulant
T136	DefiniteNP 2251 2259	the risk
T137	DefiniteNP 2444 2452	the risk
T138	ZeroArticleNP 2407 2433	drugs affecting hemostasis
T139	IndefiniteNP 2492 2517	other antiplatelet agents
T140	IndefiniteNP 2519 2539	other anticoagulants
T141	ZeroArticleNP 2550 2569	thrombolytic agents
T142	ZeroArticleNP 2571 2610	selective serotonin reuptake inhibitors
T143	ZeroArticleNP 2646 2655	inhibitor
T144	ZeroArticleNP 2661 2697	nonsteroidal anti-inflammatory drugs
T145	ZeroArticleNP 2711 2728	Drug Interactions
T146	PersonalPronoun 2827 2831	them
T147	IndefiniteNP 2853 2870	an emergency room
T148	DefiniteNP 2991 3015	the anticoagulant effect
T149	DefiniteNP 3087 3100	the last dose
T150	IndefiniteNP 3134 3153	A specific antidote
T151	DefiniteNP 3364 3390	the anticoagulant activity
T152	ZeroArticleNP 3432 3455	antifibrinolytic agents
T153	DistributiveNP 3537 3565	neither scientific rationale
T154	ZeroArticleNP 3691 3719	procoagulant reversal agents
T155	DefiniteNP 4065 4075	The safety
T156	DemonstrativeNP 4211 4225	these patients
T157	ZeroArticleNP 4229 4235	7 DRUG
T158	IndefiniteNP 4262 4273	a substrate
T159	DefiniteNP 4372 4380	the risk
T160	ZeroArticleNP 4299 4319;4324 4328	Inhibitors of CYP3A4 P-gp
T161	DefiniteNP 4465 4473	the risk
T162	ZeroArticleNP 4394 4412;4417 4421	Inducers of CYP3A4 P-gp
T163	ZeroArticleNP 4488 4529	Strong dual inhibitors of CYP3A4 and P-gp
T164	ZeroArticleNP 4660 4694	strong inducers of CYP3A4 and P-gp
T165	PersonalPronoun 4880 4882	it
T166	DefiniteNP 4813 4821	The dose
T167	ZeroArticleNP 4906 4962	drugs that are strong dual inhibitors of CYP3A4 and P-gp
T168	IndefiniteNP 5137 5143	a dose
T169	ZeroArticleNP 5396 5435	strong dual inducers of CYP3A4 and P-gp
T170	DemonstrativeNP 5504 5514	such drugs
T171	DefiniteNP 5735 5743	the risk
T172	ZeroArticleNP 5649 5668	antiplatelet agents
T173	DefiniteNP 5892 5907	the combination
T174	IndefiniteNP 5769 5804	a placebo-controlled clinical trial
T175	IndefiniteNP 5964 5977	a higher rate
T176	DefiniteNP 6025 6033	The rate
T177	ZeroArticleNP 6139 6166	single antiplatelet therapy
T178	ZeroArticleNP 6250 6275	dual antiplatelet therapy
T179	DefiniteNP 6328 6345	the bleeding risk
T180	DefiniteNP 6397 6414	the bleeding risk
T181	DemonstrativeNP 6467 6486	this clinical trial
T182	ZeroArticleNP 6520 6545	dual antiplatelet therapy
T1	Drug_Class 2407 2433	drugs affecting hemostasis
T3	Drug 2233 2240	ELIQUIS
T4	Substance 3897 3920	Activated oral charcoal
T7	Drug 3970 3978	apixaban
T8	Drug 3943 3951	apixaban
T9	Drug_Class 4299 4319	Inhibitors of CYP3A4
T10	Drug_Class 4299 4312;4324 4328	Inhibitors of P-gp
T13	Drug_Class 4394 4412	Inducers of CYP3A4
T14	Drug 4350 4358	apixaban
T16	Drug 4443 4451	apixaban
T18	Drug_Class 4394 4405;4417 4421	Inducers of P-gp
T20	Drug_Class 4488 4529	Strong dual inhibitors of CYP3A4 and P-gp
T21	Drug 4555 4563	apixaban
T24	Drug 4572 4579	ELIQUIS
T25	Drug_Class 4660 4694	strong inducers of CYP3A4 and P-gp
T26	Drug 4719 4727	apixaban
T30	Drug 4825 4832	ELIQUIS
T31	Drug_Class 4906 4962	drugs that are strong dual inhibitors of CYP3A4 and P-gp
T32	Drug 4971 4983	ketoconazole
T33	Drug 4985 4997	itraconazole
T34	Drug 4999 5008	ritonavir
T35	Drug 5013 5027	clarithromycin
T37	Drug_Class 5195 5241	strong dual inhibitors of both CYP3A4 and P-gp
T38	Drug 5126 5133	ELIQUIS
T40	Drug 5541 5549	apixaban
T41	Drug 5383 5390	ELIQUIS
T42	Drug_Class 5396 5435	strong dual inducers of CYP3A4 and P-gp
T45	Drug 5443 5451	rifampin
T46	Drug 5453 5466	carbamazepine
T47	Drug 5468 5477	phenytoin
T48	Drug 5479 5494	St. John's wort
T50	Drug_Class 5649 5668	antiplatelet agents
T51	Drug_Class 5670 5683	fibrinolytics
T52	Drug 5685 5692	heparin
T53	Drug 5694 5701	aspirin
T54	Drug_Class 5715 5720	NSAID
T55	Drug 6310 6317	aspirin
T56	Drug 6349 6356	ELIQUIS
T59	Drug 6418 6426	warfarin
T61	Drug_Class 4770 4811	Strong Dual Inhibitors of CYP3A4 and P-gp
T62	Drug_Class 5317 5356	Strong Dual Inducers of CYP3A4 and P-gp
T63	Drug_Class 2661 2697	nonsteroidal anti-inflammatory drugs
T64	Drug_Class 2498 2517	antiplatelet agents
T65	Drug_Class 5608 5627	Antiplatelet Agents
T66	Drug_Class 2699 2705	NSAIDs
T67	Drug 2480 2487	aspirin
T68	Drug 5881 5888	aspirin
T69	Drug 5911 5918	aspirin
T70	Drug_Class 2525 2539	anticoagulants
T71	Drug_Class 5589 5603	Anticoagulants
T72	Drug 1979 1987	warfarin
T73	Drug 2541 2548	heparin
T74	Drug 46 54	apixaban
T75	Drug 3019 3027	apixaban
T76	Drug 3224 3232	apixaban
T77	Drug 3394 3402	apixaban
T78	Drug 3518 3526	apixaban
T79	Drug 3674 3682	apixaban
T80	Drug 4250 4258	Apixaban
T81	Drug 5808 5816	apixaban
T82	Drug 5995 6003	apixaban
T83	Drug 6077 6085	apixaban
T84	Drug 6191 6199	apixaban
T85	Drug 26 33	ELIQUIS
T86	Drug 81 88	ELIQUIS
T87	Drug 186 193	ELIQUIS
T88	Drug 323 330	ELIQUIS
T89	Drug 424 431	ELIQUIS
T90	Drug 661 668	ELIQUIS
T91	Drug 825 832	ELIQUIS
T92	Drug 962 969	ELIQUIS
T93	Drug 1063 1070	ELIQUIS
T94	Drug 1240 1247	ELIQUIS
T95	Drug 1443 1450	ELIQUIS
T97	Drug 1543 1550	ELIQUIS
T98	Drug 1683 1690	ELIQUIS
T99	Drug 1773 1780	ELIQUIS
T100	Drug 1796 1803	ELIQUIS
T101	Drug 1968 1975	ELIQUIS
T102	Drug 2060 2067	ELIQUIS
T103	Drug 2872 2879	ELIQUIS
T104	Drug 3158 3165	ELIQUIS
T105	Drug 4092 4099	ELIQUIS
T106	Drug 4181 4188	ELIQUIS
T107	Drug 6551 6558	ELIQUIS
T108	Drug 2622 2636	norepinephrine
T109	Drug 5923 5934	clopidogrel
T5	Drug 3457 3472	tranexamic acid
T6	Drug 3474 3491	aminocaproic acid
T12	Drug 3621 3633	desmopressin
T15	Drug 3638 3647	aprotinin
T183	SPAN 2736 2744	Patients
T184	SPAN 4856 4862	2.5 mg
R12	Appositive Attribute:T141 Head:T67
R13	Appositive Attribute:T141 Head:T63
R14	Appositive Attribute:T141 Head:T64
R15	Appositive Attribute:T141 Head:T70
R16	Appositive Attribute:T141 Head:T73
R17	Appositive Attribute:T141 Head:T108
R18	PredicateNominative Attribute:T158 Head:T80
R19	Anaphora Anaphor:T170 Antecedent:T42
